A randomized phase II/III study of paclitaxel/carboplatin/metformin versus paclitaxel/carboplatin/placebo as initial therapy for measurable stage III or IVA, stage IVB, or recurrent endometrial cancer: An NRG oncology/GOG study
2020
Keywords:
- Correction
- Cite
- Save
- Machine Reading By IdeaReader
0
References
2
Citations
NaN
KQI